TYSABRI: 8,210 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
8,210
Total FAERS Reports
156 (1.9%)
Deaths Reported
1,256
Hospitalizations
8,210
As Primary/Secondary Suspect
36
Life-Threatening
21
Disabilities
First Report: 2004 · Latest Report: 20140616
What Are the Most Common TYSABRI Side Effects?
#1 Most Reported
Multiple sclerosis relapse
811 reports (9.9%)
#2 Most Reported
Fatigue
759 reports (9.2%)
#3 Most Reported
Malaise
523 reports (6.4%)
All TYSABRI Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 811 | 9.9% | 8 | 241 |
| Fatigue | 759 | 9.2% | 0 | 56 |
| Malaise | 523 | 6.4% | 1 | 37 |
| Gait disturbance | 445 | 5.4% | 2 | 32 |
| Multiple sclerosis | 443 | 5.4% | 9 | 57 |
| Memory impairment | 422 | 5.1% | 0 | 26 |
| Headache | 368 | 4.5% | 0 | 34 |
| Drug ineffective | 329 | 4.0% | 2 | 25 |
| Asthenia | 328 | 4.0% | 3 | 49 |
| Fall | 324 | 4.0% | 8 | 99 |
| Nasopharyngitis | 310 | 3.8% | 0 | 14 |
| Urinary tract infection | 308 | 3.8% | 12 | 117 |
| Pain | 274 | 3.3% | 1 | 37 |
| Balance disorder | 260 | 3.2% | 1 | 25 |
| Hypoaesthesia | 259 | 3.2% | 0 | 32 |
| Stress | 214 | 2.6% | 0 | 15 |
| Mobility decreased | 213 | 2.6% | 0 | 24 |
| Cognitive disorder | 211 | 2.6% | 0 | 15 |
| Pain in extremity | 203 | 2.5% | 1 | 25 |
| Influenza | 201 | 2.5% | 0 | 27 |
Who Reports TYSABRI Side Effects? Age & Gender Data
Average age: 46.4 years. Most reports from: US. View detailed demographics →
Is TYSABRI Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 2 | 0 | 1 |
| 2005 | 5 | 0 | 0 |
| 2006 | 6 | 0 | 1 |
| 2007 | 33 | 0 | 7 |
| 2008 | 56 | 0 | 14 |
| 2009 | 59 | 1 | 13 |
| 2010 | 90 | 1 | 26 |
| 2011 | 145 | 7 | 48 |
| 2012 | 332 | 11 | 94 |
| 2013 | 1,728 | 51 | 447 |
| 2014 | 2,367 | 24 | 355 |
What Is TYSABRI Used For?
| Indication | Reports |
|---|---|
| Multiple sclerosis | 7,629 |
| Relapsing-remitting multiple sclerosis | 198 |
| Product used for unknown indication | 190 |
| Crohn's disease | 157 |
| Maternal exposure timing unspecified | 15 |
| Exposure via father | 5 |
TYSABRI vs Alternatives: Which Is Safer?
TYSABRI vs TYVASO
TYSABRI vs UBIDECARENONE
TYSABRI vs UBLITUXIMAB
TYSABRI vs UBLITUXIMAB-XIIY
TYSABRI vs UBROGEPANT
TYSABRI vs ULIPRISTAL
TYSABRI vs UMBRALISIB
TYSABRI vs UMECLIDINIUM
TYSABRI vs UMECLIDINIUM\VILANTEROL TRIFENATATE
TYSABRI vs UMIFENOVIR
Official FDA Label for TYSABRI
Official prescribing information from the FDA-approved drug label.